The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
Hodgkin's Lymphoma 2012
DOI: 10.5772/33651
|View full text |Cite
|
Sign up to set email alerts
|

Recent Insights into the Biology of Hodgkin's Lymphoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 144 publications
0
1
0
Order By: Relevance
“…For most lymphomas, the standard treatment is combination chemotherapy involving doxorubicin, bleomycin, vinblastine, and/ or dacarbazine (Younes, 2016); however, in certain subtypes of lymphoma cancer, radiotherapy may be used as a single treatment modality (Banerjee, 2012). Over the past decade, newly developed target agents and monoclonal antibodies have been incorporated into many lymphoma treatment approaches (Stathis, 2016).…”
mentioning
confidence: 99%
“…For most lymphomas, the standard treatment is combination chemotherapy involving doxorubicin, bleomycin, vinblastine, and/ or dacarbazine (Younes, 2016); however, in certain subtypes of lymphoma cancer, radiotherapy may be used as a single treatment modality (Banerjee, 2012). Over the past decade, newly developed target agents and monoclonal antibodies have been incorporated into many lymphoma treatment approaches (Stathis, 2016).…”
mentioning
confidence: 99%